Show simple item record

dc.contributor.authorMichelena, Xabier
dc.contributor.authorZhao, Sizheng Steven
dc.contributor.authorDubash, Sayam
dc.contributor.authorDean, Linda E
dc.contributor.authorJones, Gareth T
dc.contributor.authorMarzo-Ortega, Helena
dc.date.accessioned2021-12-07T13:36:00Z
dc.date.available2021-12-07T13:36:00Z
dc.date.issued2021-12-01
dc.identifier.citationMichelena , X , Zhao , S S , Dubash , S , Dean , L E , Jones , G T & Marzo-Ortega , H 2021 , ' Similar biologic drug response regardless of radiographic status in axial spondyloarthritis : data from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis registry ' , Rheumatology , vol. 60 , no. 12 , pp. 5795-5800 . https://doi.org/10.1093/rheumatology/keab070en
dc.identifier.issn1462-0324
dc.identifier.otherPURE: 190694150
dc.identifier.otherPURE UUID: dbfbbfb3-6731-43d2-bf34-c1c660b22395
dc.identifier.otherPubMed: 33502476
dc.identifier.otherORCID: /0000-0003-0016-7591/work/93483283
dc.identifier.otherScopus: 85122546497
dc.identifier.urihttps://hdl.handle.net/2164/17630
dc.descriptionAcknowledgements: We acknowledge Prof. Gary J. MacFarlane as chief investigator on the BSRBR-AS study. We are grateful to the staff of the BSRBR-AS register and to the recruiting staff at the clinical centres, details of which are available at www.abdn.ac.uk/bsrbr-as. H.M.O. designed the study proposal. X.M. analysed the data and wrote the manuscript, with significant input from all co-authors. G.T.J. is deputy chief investigator on the BSRBR-AS study and together with L.D. discussed results and provided input into drafts of the manuscript. The study was approved by the National Research Ethics Service Committee North East-County Durham and Tees Valley (reference 11/NE/0374) and informed consent was obtained from all participants. Funding: This work was supported by a research grant from the FOREUM Foundation for Research in Rheumatology. The BSRBR-AS is funded by the British Society for Rheumatology, which received funding for this from Pfizer, AbbVie and UCB. They have no input in determining the topics for analysis or work involved in undertaking it.en
dc.format.extent6
dc.language.isoeng
dc.relation.ispartofRheumatologyen
dc.rights© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.comen
dc.subjectankylosing spondylitisen
dc.subjectepidemiologyen
dc.subjectbiological therapyen
dc.subjectdrug survivalen
dc.subjectaxial spondyloarthritisen
dc.subjectR Medicineen
dc.subjectOtheren
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.titleSimilar biologic drug response regardless of radiographic status in axial spondyloarthritis : data from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis registryen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Clinical Medicineen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Epidemiology Groupen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH)en
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1093/rheumatology/keab070
dc.identifier.vol60en
dc.identifier.iss12en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record